Journal
CURRENT PULMONOLOGY REPORTS
Volume 1, Issue 3, Pages 162-167Publisher
SPRINGER
DOI: 10.1007/s13665-012-0017-x
Keywords
Lung transplantation; Immunocompromised; Rhinovirus; Adenovirus; Influenza; Parainfluenza; Respiratory syncytial virus; Human metapneumovirus; Ribavirin; Acute rejection; Bronchiolitis obliterans syndrome; PCR
Categories
Funding
- Alnylam Pharmaceuticals
Ask authors/readers for more resources
Community-acquired respiratory viruses (CARVs) are common pathogens in lung transplant recipients. Infection due to these viruses is associated with multiple complications including: rhinitis, pharyngitis, bronchitis, pneumonia, respiratory failure and even death. CARVs have also become increasingly recognized as a risk factor for acute rejection (AR) and bronchiolitis obliterans syndrome (BOS). Newer diagnostic techniques have enhanced the accuracy of diagnosis, but proven treatment options for CARVs are limited. Further insight into the immune response and allograft dysfunction associated with CARV infections is needed in order to develop novel management strategies which can reduce the morbidity and mortality caused by these infectious agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available